Eli Casdin
Director at Standard Biotools Inc. (LAB); Director at GeneDx Holdings Corp. (WGS)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
82
Avg. 90-day return+27.4%
vs. S&P 500+22.7%
Beat the market50%
Paper profit on buys+$1.7M
Total bought / sold$12.5M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 8SEC | WGSGeneDx Holdings Corp. | Buy | 150,0003,657,164 held (+4%) | $56.44 | $8.5M | +19.3% |
| Jun 8SEC | WGSGeneDx Holdings Corp. | Buy | 50,0003,707,164 held (+1%) | $52.86 | $2.6M | +27.4% |
| Nov 20SEC | LABStandard Biotools Inc. | Buy | 275,00063,250,000 held (+0%) | $1.23 | $338K | -43.9% |
| Nov 20SEC | LABStandard Biotools Inc. | Buy | 350,00063,600,000 held (+1%) | $1.28 | $448K | -46.1% |
| Nov 20SEC | LABStandard Biotools Inc. | Buy | 450,00064,050,000 held (+1%) | $1.30 | $585K | -46.9% |
- Buy
Director Eli Casdin bought $8.5M of WGS at $56.44 — first open-market purchase in our records.
- Buy
Director Eli Casdin bought $338K of LAB at $1.23 — first open-market purchase in our records.
- Buy
Director Eli Casdin bought $448K of LAB at $1.28 — largest purchase by this insider in our records.
- Buy
Director Eli Casdin bought $585K of LAB at $1.30 — largest purchase by this insider in our records.